Daurismo

Glasdegib, sold under the brand name Daurismo, is a medication for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults older than 75 years or those who have comorbidities that preclude use of intensive induction chemotherapy.[3][4][5] It is taken by mouth and is used in combination with low-dose cytarabine.[4] The recommended dose of glasdegib is 100 mg orally once daily on days 1 to 28 in combination with cyt... [wikipedia]